NTRK2 and neoplasm: Applying a treatment with a TRKB specific inhibitor, we demonstrate the selective effects of TRKB blockage on TRKBhigh/BDNFhigh MD/PD-OSCC tumor cell proliferation and migration in in vitro or in vivo assay systems.